A Novel Microfiber Wipe for Delivery of Active Substances to Human Skin: Clinical Proof of Concept
- PMID: 33212837
- PMCID: PMC7697972
- DOI: 10.3390/polym12112715
A Novel Microfiber Wipe for Delivery of Active Substances to Human Skin: Clinical Proof of Concept
Abstract
A novel technology for the delivery of active substances to the skin based on microfibers loaded with dried active substances was developed. The objective of this work was to demonstrate deposition of the active substances on the skin including concurrent cleansing properties of the wipe. As model active substance to measure deposition capacity Niacinamide was used and as parameter to measure cleansing capacities of the wipe squalene uptake was measured. Wipes loaded with niacinamide were used in the face and the forearm of 25 subjects. By means of Raman spectrometry the deposited niacinamide was analyzed before and after application. Wipes used on the face were analyzed for squalene to assess skin cleansing properties and for residual niacinamide. Forearm analysis including placebo and verum on left and right arm respectively was performed to rule out changes of the skin through application of the tissue. Measured amounts of niacinamide from face application demonstrate statistically significant results in the study population. Analysis of the wipes used show a liberation of 28.3% of niacinamide from the wipes and an uptake of 1.7 mg squalene per wipe. Results from forearm application show statistically significant differences (p < 0.05) between placebo and active for the complete study population. Sub group analyses are significant for both gender and ethnicity for face and forearm analysis respectively. Results clearly demonstrate deposition of niacinamide on the skin and the cleansing properties of the wipe. The institutional review board approved this prospective study.
Keywords: Raman spectroscopy; liposomes; microfiber; niacinamide; skin cleansing; topical delivery.
Conflict of interest statement
This research is sponsored by FILAG Medical Schweiz AG, Switzerland. The sponsor was involved in the design and conduct of the study as well as analysis and interpretation of data and writing of manuscript. However, design, conduct, analysis of results and writing of manuscript was conducted under the supervision of authors not related to the funder. Therefore, the authors declare no conflict of interest.
Figures




Similar articles
-
Wiping conditions and fabric properties influenced the microfiber shedding from non-woven products.Environ Sci Process Impacts. 2022 Oct 19;24(10):1855-1866. doi: 10.1039/d2em00292b. Environ Sci Process Impacts. 2022. PMID: 36125181
-
Cutaneous tolerance of baby wipes by infants with atopic dermatitis, and comparison of the mildness of baby wipe and water in infant skin.J Eur Acad Dermatol Venereol. 2001 Sep;15 Suppl 1:16-21. doi: 10.1046/j.0926-9959.2001.00004.x. J Eur Acad Dermatol Venereol. 2001. PMID: 11720073 Clinical Trial.
-
Evaluation of the virucidal efficacy of disinfectant wipes with a test method simulating practical conditions.Antimicrob Resist Infect Control. 2019 Jul 16;8:121. doi: 10.1186/s13756-019-0569-4. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31346462 Free PMC article.
-
A pilot study of the in vitro antimicrobial activity and in vivo residual activity of chlorhexidine and acetic acid/boric acid impregnated cleansing wipes.BMC Vet Res. 2019 Oct 30;15(1):382. doi: 10.1186/s12917-019-2098-z. BMC Vet Res. 2019. PMID: 31666075 Free PMC article.
-
Final report of the safety assessment of niacinamide and niacin.Int J Toxicol. 2005;24 Suppl 5:1-31. doi: 10.1080/10915810500434183. Int J Toxicol. 2005. PMID: 16596767 Review.
References
-
- Egbert C. Kosmetik für Apotheker. Wissenschaftliche Verlagsgesellschaft Stuttgart; Stuttgart, Germany: 1989. pp. 97–99.
-
- Rähse W. Cosmetic Creams, Development, Manufacture and Marketing of Effective Skin Care Products. Wiley-VCH GmbH; Weinheim, Germany: 2019.
LinkOut - more resources
Full Text Sources
Research Materials